AR

Atul Ramniklal Mashru

Active Director Director DIN 09227365
DIN 09227365 First appointment Jul 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Atul Ramniklal Mashru

Data last updated:

Atul Ramniklal Mashru is a Director at Mumbai Citiclinic Private Limited (since 2021). The company operates in Healthcare. Mumbai Citiclinic Private Limited reported revenue of ₹16.98 Cr (FY 2025).

DIN 09227365
Primary Designation Director
Industry Healthcare
First Appointment 06 Jul 2021
Oldest Company Age 20 yrs
Largest company Mumbai Citiclinic Private Limited · ₹16.98 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mumbai Citiclinic Private Limited U85120MH2006PTC162808
Director06 Jul 20212006₹16.98 Cr (FY 2025)Active

Board colleagues of Atul Ramniklal Mashru

Directorship timeline

Open interactive timeline →
Mumbai Citiclinic Private Limited
Premium access

Shareholding and investment profile for Atul Ramniklal Mashru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Ramniklal Mashru

Atul Ramniklal Mashru currently holds 1 directorship: Mumbai Citiclinic Private Limited (Director, since 06 Jul 2021, revenue ₹16.98 Cr (FY 2025)).

Atul Ramniklal Mashru was first appointed on 06 Jul 2021 as Director at Mumbai Citiclinic Private Limited.

The current boards of Atul Ramniklal Mashru's companies include Kashmira Atul Mashru (Mumbai Citiclinic Private Limited), Nikita Puneet Mashru (Mumbai Citiclinic Private Limited), Puneet Atul Mashru (Mumbai Citiclinic Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available